Opus Genetics annual revenue
2009
2010
2011
2012
2013
2019
2020
2021
2022
2023
2024
2025
Opus Genetics Revenue Growth & History (IRD)
Opus Genetics reported $14.2M in revenue for fiscal 2025, an increase of 29.15% from the previous fiscal year.
View full Opus Genetics company overviewOpus Genetics annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $14.2M | $3.2M | +29.15% |
| 2024 | 2024-12-31 | $11.0M | −$8.1M | −42.30% |
| 2023 | 2023-12-31 | $19.0M | −$20.8M | −52.20% |
| 2022 | 2022-12-31 | $39.9M | $39.3M | +6665.70% |
| 2021 | 2021-12-31 | $589,000 | $589,000 | — |
| 2020 | 2020-12-31 | $0 | −$3.0M | −100.00% |
| 2019 | 2019-12-31 | $3.0M | — | — |
| 2013 | 2013-12-31 | $0 | $0 | — |
| 2012 | 2012-12-31 | $0 | $0 | — |
| 2011 | 2011-12-31 | $0 | $0 | — |
| 2010 | 2010-12-31 | $0 | $0 | — |
| 2009 | 2009-12-31 | $0 | — | — |
Opus Genetics quarterly revenue
Q2.10
Q3.10
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $755,000 | −$2.1M | −73.80% |
| Q1 2026 | 2026-03-31 | $2.2M | −$2.2M | −50.64% |
| Q4 2025 | 2025-12-31 | $3.9M | −$437,000 | −10.16% |
| Q3 2025 | 2025-09-30 | $3.1M | −$788,000 | −20.38% |
| Q2 2025 | 2025-06-30 | $2.9M | $1.8M | +159.17% |
| Q1 2025 | 2025-03-31 | $4.4M | $2.7M | +155.41% |
| Q4 2024 | 2024-12-31 | $4.3M | $2.6M | +154.41% |
| Q3 2024 | 2024-09-30 | $3.9M | −$8.1M | −67.60% |
| Q2 2024 | 2024-06-30 | $1.1M | −$2.6M | −69.73% |
| Q1 2024 | 2024-03-31 | $1.7M | −$38,000 | −2.17% |
| Q4 2023 | 2023-12-31 | $1.7M | −$38.2M | −95.76% |
| Q3 2023 | 2023-09-30 | $11.9M | $11.9M | — |
| Q2 2023 | 2023-06-30 | $3.7M | $3.7M | — |
| Q1 2023 | 2023-03-31 | $1.7M | $1.7M | — |
| Q4 2022 | 2022-12-31 | $39.9M | — | — |
| Q3 2022 | 2022-09-30 | $0 | −$489,000 | −100.00% |
| Q2 2022 | 2022-06-30 | $0 | −$100,000 | −100.00% |
| Q1 2022 | 2022-03-31 | $0 | — | — |
| Q3 2021 | 2021-09-30 | $489,000 | $489,000 | — |
| Q2 2021 | 2021-06-30 | $100,000 | $100,000 | — |
| Q4 2020 | 2020-12-31 | −$1.1M | −$1.1M | — |
| Q3 2020 | 2020-09-30 | $0 | $0 | — |
| Q2 2020 | 2020-06-30 | $0 | $0 | — |
| Q1 2020 | 2020-03-31 | $1.1M | −$1.9M | −61.67% |
| Q4 2019 | 2019-12-31 | $0 | — | — |
| Q3 2019 | 2019-09-30 | $0 | — | — |
| Q2 2019 | 2019-06-30 | $0 | — | — |
| Q1 2019 | 2019-03-31 | $3.0M | — | — |
| Q1 2014 | 2014-03-31 | $0 | $0 | — |
| Q4 2013 | 2013-12-31 | $0 | $0 | — |
| Q3 2013 | 2013-09-30 | $0 | $0 | — |
| Q2 2013 | 2013-06-30 | $0 | $0 | — |
| Q1 2013 | 2013-03-31 | $0 | $0 | — |
| Q4 2012 | 2012-12-31 | $0 | $0 | — |
| Q3 2012 | 2012-09-30 | $0 | $0 | — |
| Q2 2012 | 2012-06-30 | $0 | $0 | — |
| Q1 2012 | 2012-03-31 | $0 | $0 | — |
| Q4 2011 | 2011-12-31 | $0 | — | — |
| Q3 2011 | 2011-09-30 | $0 | $0 | — |
| Q2 2011 | 2011-06-30 | $0 | −$18,750 | −100.00% |
| Q1 2011 | 2011-03-31 | $0 | — | — |
| Q3 2010 | 2010-09-30 | $0 | — | — |
| Q2 2010 | 2010-06-30 | $18,750 | — | — |
Opus Genetics revenue growth trends
Opus Genetics's latest reported quarter, Q2 2026, generated $755,000 in revenue, a decrease of 73.80% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Opus Genetics source filings ↗